Chesley Taft & Associates LLC Has $3.23 Million Stake in iShares Biotechnology ETF $IBB

Chesley Taft & Associates LLC reduced its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 4.1% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 25,512 shares of the financial services provider’s stock after selling 1,101 shares during the quarter. Chesley Taft & Associates LLC owned approximately 0.06% of iShares Biotechnology ETF worth $3,227,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of the business. Ramirez Asset Management Inc. bought a new position in iShares Biotechnology ETF in the 1st quarter valued at $26,000. Financial Gravity Asset Management Inc. bought a new position in shares of iShares Biotechnology ETF in the first quarter valued at about $30,000. Woodside Wealth Management LLC bought a new position in shares of iShares Biotechnology ETF in the first quarter valued at about $31,000. CX Institutional acquired a new position in iShares Biotechnology ETF during the 1st quarter worth about $32,000. Finally, Garde Capital Inc. bought a new stake in iShares Biotechnology ETF during the 1st quarter worth about $36,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Stock Performance

IBB opened at $140.94 on Wednesday. iShares Biotechnology ETF has a 1-year low of $107.43 and a 1-year high of $150.57. The firm has a 50-day moving average price of $136.16 and a two-hundred day moving average price of $129.17.

iShares Biotechnology ETF Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 19th. Shareholders of record on Tuesday, September 16th will be issued a dividend of $0.0828 per share. The ex-dividend date of this dividend is Tuesday, September 16th. This represents a $0.33 annualized dividend and a yield of 0.2%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.